$860.28
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

McKesson Corp. engages in providing healthcare services. The company is headquartered in Irving, Texas and currently employs 43,000 full-time employees. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. The company also offers oncology and specialty solutions.
Country

US

CEO

Mr. Brian Tyler

IPO date

1994

Employees

43,000

ISIN

US58155Q1031

Key stats

Open

$835.06

Volume

1.58M

Market cap

$100.14B

Prev. close

$858.90

Impl / hst vl

-

Open interest

$0.00

$835.00

Day’s Range

$867.91

$723.68

52W Range

$987.37

Valuation

16
Valuation score
Strongly Overvalued
P/E
21.90
P/S
0.24
P/B
-
Current ratio
0.89
Debt / Equity
-
ROE
-
Gross margin
3.50%
Income growth
-63.50%
FCF growth
-111.50

Oct

1

Dividends

The next payment date will be Oct 1, 2026

Div. per Share

$0.94

Div. Yield

0.11%

Payout Ratio

-

Div. Growth YoY

14.63%

Analysts estimates

Consensus rating
Buy

The average rating from top 11 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$964.87
The top 18 analysts forecasts that 12-month price may increase by 12.16%, with a low of $820.12 and a high of $1,118.25
$820.12
Low
$964.87
Avg
$1,118.25
High
Current price

Earnings

Q2 ‘26 revenue
$105.38B
Q2 ‘26 net income
$614.00M
Revenue
Net income
Previous EPS
$9.86
Estimate EPS
$9.31
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply